GABAAergic dysfunction in the olivary-cerebellar-brainstem network may cause eye oscillations and body tremor.
Eye Tracking and Visual Application Laboratory (EVALab), Unit of Neurology and Metabolic Diseases, Department of Medical, Surgical, and Neurological Sciences, University of Siena, Italy; Laboratory of Sensorimotor Research, IRP, National Eye Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: elena.pretegiani@nih.gov.
Elena
E
Pretegiani
Eye Tracking and Visual Application Laboratory (EVALab), Unit of Neurology and Metabolic Diseases, Department of Medical, Surgical, and Neurological Sciences, University of Siena, Italy.
Francesca
F
Rosini
Department of Medical, Surgical, and Neurological Sciences, University of Siena, Italy.
Raffaele
R
Rocchi
Department of Medical, Surgical, and Neurological Sciences, University of Siena, Italy.
Federica
F
Ginanneschi
Eye Tracking and Visual Application Laboratory (EVALab), Unit of Neurology and Metabolic Diseases, Department of Medical, Surgical, and Neurological Sciences, University of Siena, Italy.
Claudia
C
Vinciguerra
Laboratory of Sensorimotor Research, IRP, National Eye Institute, National Institutes of Health, Bethesda, MD, USA.
Lance M
LM
Optican
Eye Tracking and Visual Application Laboratory (EVALab), Unit of Neurology and Metabolic Diseases, Department of Medical, Surgical, and Neurological Sciences, University of Siena, Italy.
Alessandra
A
Rufa
D000328:Adult; D001933:Brain Stem / Q000503:physiopathology*; D002531:Cerebellum / Q000503:physiopathology*; D006801:Humans; D008297:Male; D015835:Ocular Motility Disorders / Q000139:chemically induced / Q000503:physiopathology*; D009847:Olivary Nucleus / Q000503:physiopathology*; D058573:Performance-Enhancing Substances / Q000009:adverse effects*; D014202:Tremor / Q000209:etiology / Q000503:physiopathology*
D058573:Performance-Enhancing Substances